Facebook
Twitter
LinkedIn
ForwardClick here to search courses using NAPNAP's previous Course Catalog layout.
Title
Category
Credits
Event date
Cost
- Primary Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. The presenters will address four chronic health conditions that can present challenges to the pediatric-focused NP in a primary care clinic: congenital heart disease, chronic renal failure, post traumatic brain injury and cystic fibrosis. Clinical experts will present the primary care needs of children with medical complexity, which may be different from other children coming to your clinic, including vaccination schedules, medications, developmental considerations and when to call the specialist.
- Primary Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This presentation will cover the latest research, new medications and updated practice guidelines in pediatric migraine management as well as how to evaluate and use the current evidence in practice.
- Primary Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Penicillin allergy, the most commonly reported allergy in a pediatric patient, is associated with increases in cost of care, hospitalization and morbidity, as well as contributing to antibiotic resistance. However, 95% of patients labeled with a penicillin allergy do not have a true allergy. The Centers for Disease Control & Prevention has identified improper use of antibiotics to be an important factor that must be addressed for both patient safety and public health. This presentation will identify high-risk symptoms of allergy, differentiate between adverse reactions, IgE-mediated allergic reaction and delayed T-cell reactions, as well as discuss appropriate testing for penicillin allergy. Additionally, the presenter will address alternative antibiotics that can be used until a formal allergy evaluation can be completed.
- Primary Care
- Infectious Disease
- Pharmacology CE
- 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is an archived presentation from NAPNAP's 2023 National Conference.
Antibiotics are the most commonly prescribed medications in pediatrics. This presentation will review current antibiotic resistance patterns and provide a rapid-fire review of current guidelines for prescribing antibiotics for pediatric patients.
- Primary Care
- FREE for Members
- Immunization
- Pharmacology CE
- 1.25 Contact hours
$12.50
1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is free for NAPNAP Members. For non-members, this continuing education activity rate is $12.50. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23.
While presenting the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines.
- Primary Care
- Infectious Disease
- Immunization
- Pharmacology CE
- 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23.
Children and adolescents are at risk for developing a wide variety of viral infections. This presentation will discuss how to prevent and treat a wide variety of viral infections seen in children.
- Primary Care
- Acute Care
- Nutrition/Feeding
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which 1.0 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23.
Quality care for children with multiple chronic conditions including a neurodevelopmental disorder requires a complex plan of care. This interactive presentation will walk participants through the lives and management of three different children with multiple chronic conditions in their primary care medical home. The presenter will describe evidence-based, family-centered care of diagnoses including constipation, gastroesophageal reflux, sialorrhea, sleep disturbance and tone management. The fictional patients will represent children with cerebral palsy, genetic conditions and autism.
- Primary Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which 1.0 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10.00 for NAPNAP Members. For non-members, this continuing education activity rate is $20.00. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23.
Designed for early career pediatric-focused APRNs, this presentation will review key components of prescribing oral contraceptive pills. Both progestin-only and combined hormonal contraceptives will be included. Attendees will leave feeling confident in their ability to prescribe and manage adolescents who desire oral contraceptive pills for not only contraception, but also dysmenorrhea and acne management.
- Primary Care
- Pharmacology CE
- 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23.
Atopic dermatitis disease can vary from very mild to very severe. Proper treatment can be challenging even for the most seasoned provider. We will review case presentations with photos of mild, mild-moderate and severe atopic dermatitis management along with recommended treatment and pit fall strategies. This presentation will offer an online algorithm and newly developed app to guide the clinician in atopic dermatitis recommended care. Dupilumab biologic medication is transforming patients’ lives with moderate – severe atopic dermatitis. A patient’s experience with dupilumab treatment will be shared.
- Primary Care
- FREE for Members
- Pharmacology CE
- 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour, 1.0 pharmacology contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. Before 2018, there were no U.S. Food and Drug Administration approved medications for managing seizures in Dravet syndrome (DS). Common agents used in the antiepileptic drug regimens of patients with DS included clobazam, valproic acid, topiramate, and levetiracetam, among others; however, these agents alone rarely provide adequate seizure control. Management of seizures in DS changed in recent years with the approval of cannabidiol and stiripentol in 2018 and fenfluramine in 2020. This continuing education article summarizes available efficacy and safety data involving cannabidiol, stiripentol, and fenfluramine and provides a practical review of dosing strategies, pharmacokinetics, and monitoring interventions relevant to their use. J Pediatr Health Care. (2022)
36, 479−488